Compare Abbott Laboratories (ABT) vs Vanguard Total International Bond Index Fund ETF (BNDX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Vanguard Total International Bond Index Fund ETF — how do they compare? Abbott Laboratories trades at $95.61 (market cap $166.94B), while Vanguard Total International Bond Index Fund ETF trades at $47.83. The key difference: Abbott Laboratories pays a 2.63% dividend while Vanguard Total International Bond Index Fund ETF pays none, and Abbott Laboratories is trading nearer its 52-week high, Vanguard Total International Bond Index Fund ETF nearer its low. Which is the better fit depends on your goals.
| ABT | BNDX | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | — |
52-Week High | $136.62 | $49.91 |
52-Week Low | $82.57 | $47.57 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
BNDX is trading at $48.02, down 0.46% on the day, with technical indicators showing a bearish trend as moving averages signal selling pressure. The ETF maintains consistent dividend distributions of $0.11 per share scheduled through mid-2026. Current market sentiment reflects uncertainty around Federal Reserve policy direction, with bond ETF flows showing increased investor interest in fixed income amid stock market volatility.
The outlook for BNDX remains tied to interest rate expectations and bond market dynamics. While the ETF offers income stability through regular dividends, potential Fed rate hikes could pressure bond prices. Investors seeking reliable income may find value, but should monitor monetary policy developments closely given the current bearish technical setup.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Vanguard Total International Bond Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the Bloomberg Global Aggregate ex-USD Float Adjusted RIC Capped Index (USD Hedged). This index provides a broad-based measure of the global, investment-grade, fixed-rate debt markets. It is non-diversified.
Read more on BNDX →
